Retrophin Inc (NASDAQ:RTRX)

20.05
Delayed Data
As of Apr 18
 -0.14 / -0.69%
Today’s Change
19.57
Today|||52-Week Range
33.00
-11.40%
Year-to-Date
No recent news for Retrophin Inc.

Today’s Trading

Previous close20.19
Today’s open20.17
Day’s range19.57 - 20.33
Volume330,591
Average volume (3 months)349,479
Market cap$914.5M
Data as of 4:00pm ET, 04/18/2019

Growth & Valuation

Earnings growth (last year)-64.90%
Earnings growth (this year)-50.26%
Earnings growth (next 5 years)+137.00%
Revenue growth (last year)+6.01%
P/E ratioNM
Price/Sales5.57
Price/Book2.87

Competitors

 Today’s
change
Today’s
% change
BCRXBioCryst Pharmaceuti...+0.23+2.99%
ANIPANI Pharmaceuticals ...-0.12-0.17%
EIDXEidos Therapeutics I...+0.20+0.86%
RYTMRhythm Pharmaceutica...+0.83+3.27%
Data as of 4:00pm ET, 04/18/2019

Financials

Next reporting dateMay 6, 2019
EPS forecast (this quarter)-$0.45
Annual revenue (last year)$164.2M
Annual profit (last year)-$102.7M
Net profit margin-62.51%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Eric Dube
Chief Operating Officer
Neil F. McFarlane
Corporate headquarters
San Diego, California

Forecasts